Dillard’s (DDS) Stock Today: Special Dividend Fallout, Q3 Results, and the Latest Analyst Forecasts (Dec. 16, 2025)

Dillard’s (DDS) Stock Today: Special Dividend Fallout, Q3 Results, and the Latest Analyst Forecasts (Dec. 16, 2025)

Dillard’s, Inc. (NYSE: DDS) is having one of those “only-in-markets” weeks: the stock recently tagged fresh highs, investors chased a $30 special dividend, and now the share price is digesting both the rally and the dividend mechanics. As of Tuesday, Dec. 16, 2025, DDS was trading around $645.61, down roughly 4.9% on the day, after opening near $678 and swinging between about $629 and $688. StockAnalysis That pullback follows a dramatic run into mid-December. Multiple market data services show DDS reaching an all-time high around $740–$742 on Dec. 11, 2025. TradingView+1 So what’s actually driving Dillard’s stock right now—and what
Shopify Stock (SHOP) News and Forecasts for Dec. 16, 2025: Insider Sale, Holiday Momentum, and Analyst Price Targets in Focus

Shopify Stock (SHOP) News and Forecasts for Dec. 16, 2025: Insider Sale, Holiday Momentum, and Analyst Price Targets in Focus

Shopify Inc. (ticker: SHOP) is back in the spotlight on December 16, 2025, as investors weigh a fresh round of insider-trading headlines, institutional filings, and a widening debate over how much growth is already priced into the stock heading into 2026. As of a 2:06 p.m. ET (pricing delayed) snapshot published on Shopify’s investor relations site, SHOP was quoted at $161.92 in the U.S. with an intraday range of $155.66 to $163.34, and a prior close of $159.85—a reminder of how quickly sentiment can swing in high-multiple, high-expectations software names. Shopify Investors Below is what’s driving the conversation today—plus what
Accenture (ACN) Stock News Today: Morgan Stanley Upgrade, DLB Data Center Deal, and What to Watch Ahead of Earnings

Accenture (ACN) Stock News Today: Morgan Stanley Upgrade, DLB Data Center Deal, and What to Watch Ahead of Earnings

Accenture plc (NYSE: ACN) enters mid-December with two stock-moving narratives colliding at once: a fresh Wall Street vote of confidence and another targeted step deeper into the AI infrastructure buildout. On Tuesday, December 16, 2025, Morgan Stanley upgraded Accenture to Overweight and lifted its price target to $320, citing a “valuation floor” and early signs of demand stabilization and recovery. Investing.com+1 At the same time, Accenture announced it signed an agreement to acquire a 65% majority stake in DLB Associates, a U.S.-based engineering and consulting firm focused on data center development—an increasingly strategic corner of the AI economy as hyperscalers
AST SpaceMobile (ASTS) Stock News and Forecasts for Dec. 16, 2025: BlueBird‑6 Launch Update, Insider Sales, and Analyst Targets

AST SpaceMobile (ASTS) Stock News and Forecasts for Dec. 16, 2025: BlueBird‑6 Launch Update, Insider Sales, and Analyst Targets

AST SpaceMobile, Inc. (NASDAQ: ASTS) is back at the center of market attention on December 16, 2025, as investors weigh two forces that often dominate high-volatility “story stocks”: execution risk (a near-term satellite launch milestone) and sentiment shocks (notably, large shareholder selling revealed in SEC filings). As of the latest available trading data on Dec. 16, ASTS was around $66.30, down about 2.2% on the day, after opening near $65.50 and trading between roughly $65.35 and $68.76. That weakness follows a sharp Monday slide: ASTS closed at $67.81 on Dec. 15, down about 11.6%, amid heavy volume and a swirl
Biotech Stocks Today: FDA Fast Track Wins, PDUFA Delays and Deal Flow Move GLUE, ALDX, ADAG, PVLA as XBI and IBB Slide

Biotech Stocks Today: FDA Fast Track Wins, PDUFA Delays and Deal Flow Move GLUE, ALDX, ADAG, PVLA as XBI and IBB Slide

Updated: Tuesday, December 16, 2025 | Early afternoon ET (U.S. stock market) Biotechnology stocks are delivering a classic split-screen session in the U.S. market today: biotech ETFs are slipping, but a handful of single-name biotech movers are swinging sharply on FDA updates, clinical data, and year-end dealmaking. By early afternoon in New York (based on the latest available quotes at the time of writing), the SPDR S&P Biotech ETF (XBI) was down about 1.1%, while the iShares Biotechnology ETF (IBB) was also off about 1.1%—both lagging the broader tape. That “ETFs down, catalysts up (or down) even more” pattern is a big part of what makes biotech stocks today a headline
Philip Morris International (PM) Stock News Today (Dec. 16, 2025): Price Action, Dividend Update, ZYN & IQOS Catalysts, and Analyst Forecasts

Philip Morris International (PM) Stock News Today (Dec. 16, 2025): Price Action, Dividend Update, ZYN & IQOS Catalysts, and Analyst Forecasts

Philip Morris International Inc. (NYSE: PM) traded around $158 on Tuesday, December 16, 2025, slipping modestly after a strong prior session. As of the latest available quote, PM was near $157.93, down about 0.3% on the day, with an intraday range roughly spanning $157.51 to $159.51. The bigger story for investors isn’t the small day-to-day move—it’s the steady drumbeat of dividend visibility, smoke-free growth (ZYN and IQOS), and a dense 2026 catalyst calendar led by U.S. regulatory milestones. Here’s what matters for PM stock right now, using the major headlines, forecasts, and analysis circulating on 16.12.2025. PM stock price today:
Renewable Energy Stocks Today (Dec. 16, 2025): Sunrun, Enphase, SolarEdge and First Solar in Focus

Renewable Energy Stocks Today (Dec. 16, 2025): Sunrun, Enphase, SolarEdge and First Solar in Focus

Renewable energy stocks in the U.S. are trading mixed in Tuesday’s session as investors balance a softer risk tone on Wall Street with a powerful long-term tailwind: rapidly rising electricity demand—especially from AI data centers—and the buildout of “time-to-power” infrastructure like utility-scale solar, battery storage, and distributed energy resources. By early afternoon in New York (around 1:45–2:30 p.m. ET), major indexes were lower, with energy among the weakest S&P 500 sectors as crude slid to its lowest level since 2021, according to Reuters. Reuters That macro setup matters for clean energy too: many renewable developers and equipment makers are highly sensitive to
Energy Storage Stocks Today: Tesla, Fluence, Enphase, Sunrun and Albemarle React as AI Data Centers, Policy Deadlines and Lithium Forecasts Collide (Dec. 16, 2025)

Energy Storage Stocks Today: Tesla, Fluence, Enphase, Sunrun and Albemarle React as AI Data Centers, Policy Deadlines and Lithium Forecasts Collide (Dec. 16, 2025)

NEW YORK — Tuesday, Dec. 16, 2025 (early afternoon ET). Energy storage stocks are back in the spotlight on the U.S. stock market today, driven by three forces that rarely hit at the same time: (1) a fast-moving surge in electricity demand tied to AI data centers, (2) shifting incentives and supply-chain rules that are reshaping solar-plus-storage and grid batteries, and (3) a new round of lithium demand forecasts that explicitly prioritize energy storage system (ESS) shipments—not just installations. That mix is creating unusually sharp differentiation inside the “energy storage” theme. Some names are moving on customer wins, partnerships and project pipelines; others
Cybersecurity Stocks Today: Okta Rallies on Jefferies Upgrade as Palo Alto Warns on AI Cloud Attacks and Fortinet Targets NVIDIA “AI Factory” Security (Dec. 16, 2025)

Cybersecurity Stocks Today: Okta Rallies on Jefferies Upgrade as Palo Alto Warns on AI Cloud Attacks and Fortinet Targets NVIDIA “AI Factory” Security (Dec. 16, 2025)

NEW YORK — Dec. 16, 2025 (early afternoon ET) — Cybersecurity stocks are showing relative resilience Tuesday even as the broader U.S. market tilts lower on a mix of delayed economic data, sector rotations, and renewed sensitivity to rates. By around 2:00 p.m. ET, Reuters reported the Dow down ~0.63%, the S&P 500 down ~0.42%, and the Nasdaq off ~0.06%, as investors digested a delayed jobs report and reassessed the Federal Reserve outlook for 2026. Reuters Against that backdrop, cybersecurity names are trading on a familiar set of late-2025 themes: AI expanding the attack surface, identity security moving to the top of budgets, and vendor consolidation/platformization shaping both fundamentals and
Intuit (INTU) Stock Forecast 2026: Latest News, Price Targets and Key Levels (Dec. 16, 2025)

Intuit (INTU) Stock Forecast 2026: Latest News, Price Targets and Key Levels (Dec. 16, 2025)

December 16, 2025 — Intuit Inc. (NASDAQ: INTU) is back in focus today after a sharp dip to start the week, fresh analyst target adjustments, and a wave of institutional-position updates that highlight how heavily owned the stock remains. After closing Monday at $654.60 (down 2.43%), INTU rebounded in Tuesday trading, swinging between the mid-$650s and high-$660s as investors weighed a still-bullish (but trimmed) price target from Wolfe Research, mixed sentiment across high-multiple software, and the company’s AI-driven product roadmap heading into the 2026 tax season. MarketWatch+1 INTU stock today: price action and what it’s signaling on Dec. 16 Intuit
ABIVAX Société Anonyme (ABVX) Stock News on Dec. 16, 2025: Shares Slide After Q3 Loss Widens, While Analysts Keep Buy Calls and M&A Talk Lingers

ABIVAX Société Anonyme (ABVX) Stock News on Dec. 16, 2025: Shares Slide After Q3 Loss Widens, While Analysts Keep Buy Calls and M&A Talk Lingers

December 16, 2025 — ABIVAX Société Anonyme (listed as ABVX on Euronext Paris and Nasdaq) is back in the spotlight today after publishing third-quarter 2025 financial results and reiterating a long cash runway—news that didn’t stop the stock from pulling back as investors digested widening losses and the sheer scale of the rally already priced in. In U.S. trading, Abivax’s Nasdaq-listed shares were down about 5% around mid-session, at roughly $111–$112. StockAnalysis In Paris, Abivax shares were also lower earlier in the day, with one market report citing a drop of about 5.7% during the European morning. Investing.com South Africa
Quantum Stocks Today in the U.S. Stock Market: IONQ, QBTS, RGTI, QUBT and ARQQ Move on Jefferies Coverage and Deal News (Dec. 16, 2025)

Quantum Stocks Today in the U.S. Stock Market: IONQ, QBTS, RGTI, QUBT and ARQQ Move on Jefferies Coverage and Deal News (Dec. 16, 2025)

NEW YORK — Dec. 16, 2025 (early afternoon ET) — Quantum computing stocks are back in the spotlight Tuesday as a fresh wave of Wall Street coverage lands on the sector and deal news adds another catalyst for the most speculative names. The headline driver: Jefferies initiated coverage on key “pure-play” quantum computing companies, handing Buy ratings to IonQ (IONQ) and D-Wave Quantum (QBTS) while starting Rigetti (RGTI) at Hold. Investing.com The moves are happening even as the broader market trades with a cautious tone after economic data, with IonQ specifically highlighted among notable movers on the day. Barron’s Quantum stocks snapshot (U.S.-listed) — prices as of ~2:26

Stock Market Today

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

7 February 2026
ST Engineering shares fell 1.9% to S$9.71 Friday, outpacing the Singapore market’s 0.8% drop amid a tech-led selloff. The company signed a deal with Shield AI at the Singapore Airshow to integrate autonomy software into its unmanned platforms and unveiled a small drone capable of carrying explosives. About 6.9 million shares traded as investors await full-year results on Feb. 27.
Go toTop